Seyed Aria Nejadghaderi

FULL-NAME:               Seyed Aria Nejadghaderi

E-MAIL:                      [email protected]

[email protected]

[email protected]

Address:                    HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

GRADUATE AND POSTGRADUATE

• 2016 – 2023: Medical Doctor (M.D.), School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran


• 2021- 2023: Master of Public Health (MPH), School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran


• 2021- 2023: Master of Health Professions Education (MHPE), Virtual School of Medical Education and Management, Shahid Beheshti University of Medical Sciences, Tehran, Iran


• 2021- 2023: Geriatric research diploma, Tehran University of Medical Sciences, Tehran, Iran

UNDERGRADUATE

• 2015 – 2016: Pre-university course in Biology, National Organization for Development of Exceptional Talents (NODET), Rafsanjan, Iran


• 2012 – 2015: High school diploma in Biology, National Organization for Development of Exceptional Talents (NODET), Rafsanjan, Iran

• Research Fellow, HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran, April 2024- Present


• Research Fellow, Knowledge Hub for Migrant and Refugee Health, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran, June 2025- Present


• Research Assistant, Non-Communicable Disease Research Center (NCDRC), Endocrinology and metabolism population sciences institute, Tehran University of Medical Sciences, Tehran, Iran, May 2019 – April 2024


• Research assistant, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran, March 2021 – April 2024


• Researcher, Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran, October 2019 – December 2024


• Researcher, Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran, March 2020 – January 2025


• Global Burden of Disease (GBD) Collaborator, Institute for Health Metrics and Evaluation (IHME), University of Washington, WA, USA, May 2021 – Present


• Research Mentor, MSRC Research Academy, Medial Student Research Committee, Iran University of Medical Sciences, Tehran, Iran, October - November 2020  


• Member of the executive committee, 1^st National Conference of Blood-Borne Infections Management and Control, October 2018, Mashhad, Iran


• Participating in “Roban Ghermez” campaign, an awareness campaign for HIV/AIDS, Iranian’s medical students’ association (IMSA)-IFMSA, December 2018, Tehran, Iran


• Participating in a campaign for increasing public awareness about air pollution, Iranian’s medical students’ association (IMSA)- member of IFMSA in Iran, January 2019, Tehran, Iran


• Editorial Board Membership:




• PLOS ONE


• European Journal of Medical Research


• BMC Public Health




• Peer reviewing for the following journals:




• Scientific Reports; BMC Public Health; Frontiers in Public Health; BMC Cancer; Plos One; International Journal of Aging; Addiction & Health; Neuroepidemiology; BMC Women's Health; Journal of Advanced Research; BMC Infectious Diseases; Frontiers in Medicine; Frontiers in Endocrinology; Frontiers in Immunology; Frontiers in Oncology; Heliyon; Journal of Clinical Medicine; Risk Management and Healthcare Policy; Cancer Reports; Clinical Epidemiology and Global Health; Frontiers in Cardiovascular Medicine; Frontiers in Neurology; International Journal of Colorectal Disease; Journal of Cancer Research and Clinical Oncology; World Journal of Surgical Oncology; Annals of Epidemiology; Arab Journal of Gastroenterology; BMC Emergency Medicine; BMJ Open; Biomarker Research; Biomarkers in Medicine; Cancer Epidemiology; Cancer Epidemiology Biomarkers & Prevention; Chemosphere; Ecotoxicology and Environmental Safety; Global Health, Epidemiology and Genomics; Health Science Reports; IScience; International Journal for Equity in Health; Journal of Epidemiology and Global Health; Journal of Health, Population and Nutrition; Journal of Open Innovation: Technology, Market, and Complexity; Medical Hypotheses; Reproductive Health; Revista Panamericana de Salud Publica/Pan American Journal of Public Health; Thyroid Research; AIDS Research and Therapy; Aging Clinical and Experimental Research; American Journal of Preventive Medicine; BMC Endocrine Disorders; BMC Gastroenterology; BMC Geriatrics; BMC Medicine; BMC Neurology; BMC Psychiatry; BMC Psychology; BMC Pulmonary Medicine; BMC Urology; Cancer Cell International; Cancer Medicine; Cardiology; Child and Adolescent Psychiatry and Mental Health; Discover Oncology; European Journal of Clinical Microbiology & Infectious Diseases; European Journal of Medical Research; Experimental Hematology & Oncology; Frontiers in Clinical Diabetes and Healthcare; Frontiers in Digital Health; Frontiers in Nutrition; Immuno-Oncology Technology; Infectious Diseases and Therapy; International Journal of Cancer; International Journal of Social Determinants of Health and Health Services; JMIR Cancer; Lipids in Health and Disease; Musculoskeletal Science and Practice; Nutrition & Diabetes; Pain Research and Management; Postgraduate Medicine; Preventive Medicine Reports; Respiratory Research; The Lancet Global Health; The Lancet Regional Health - Western Pacific.

• Rank 94 in Iranian university entrance exam in natural sciences field among more than 500,000 participants, 2016


• Member of the National Organization for Development of Exceptional Talents (NODET) of Iran


• Top 2% highly cited researcher 2024 by Stanford University (Ioannidis, John P.A. (2024), “August 2024 data-update for "Updated science-wide author databases of standardized citation indicators"”, Elsevier Data Repository, V7, doi: 10.17632/btchxktzyw.7)

• Project Manager, Development of a Framework for Monitoring and Evaluation of Societal Enablers (10-10-10 Targets), related to the 2021-2026 Global AIDS Strategy, Supported by UNAIDS, December 2024


• Project Manager, Investigating Management Strategies to Control the Aedes Mosquito and Diseases Transmitted by It in Selected Countries, Supported by the Secretariat of the Supreme Council for Health and Food Security, Iranian Ministry of Health and Medical Education, September 2024


• Collaborator, Assessment and Planning for Interventions Related to the Control of Vector-Borne Diseases with an Emphasis on Dengue Fever, Supported by the Iran Centers for Disease Control and Prevention (CDC), Iranian Ministry of Health and Medical Education, April 2025


• Collaborator, Assessing the Vaccination Coverage and Barriers to Immunization among Mothers and Children Under 3 Years Old in Iran, Supported by the World Health Organization, Iran Office, August 2025

• Public health


• Epidemiology


• Non-communicable diseases


• Cancer epidemiology


• Infectious diseases


• Burden of diseases

• Tutor, Workshop on Systematic Review, Department of Research Development and Evaluation, Kerman University of Medical Sciences, Kerman, Iran, July 13–14, 2025

• Introduction to Excel software workshop, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran, May 2020


• USERN Workshop, Basic R, Children's Medical Center, August 2019


• USERN Workshop, Advanced R, Children's Medical Center, August 2019


• USERN Workshop, Advanced Statistics, Children's Medical Center, August 2019


• USERN Workshop, Scientific Research and Methodology, Children's Medical Center, September 2018


• USERN Workshop, Scientific Writing, Children's Medical Center, September 2018


• USERN Workshop, Basic Data Analysis in SPSS, Tehran University of Medical Sciences (TUMS), September 2018


• USERN Workshop, Systematic Review and Meta-analysis, Tehran University of Medical Sciences (TUMS), September 2018


• USERN Workshop, Submission and Peer Reviewing of Assignments, Children's Medical Center, September 2018


• USERN Workshop, Publishing Academic Book with International Publishers, Children's Medical Center, September 2018


• Elementary Photoshop training course, The University of Tehran, May 2018


• Search strategy workshop, Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, October 2018


• Endnote software workshop, Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, October 2018


• Statistical skills:




• Statistical software: SPSS (basic level)




• Computer skills:




• Being familiar with graphical software: Adobe Photoshop (basic level)


• Other: Microsoft Office (Advanced level), Review Manager (basic level), R programming (basic level), STATA (basic level)

• Outside interests: Jogging and Reading

1. Nejadghaderi SA, Heidari A, Shakerian N, Saghazadeh A, Rezaei N. Cardiovascular system is at higher risk of affecting by COVID-19. Acta Biomed. 2020;91(3):e2020018. Published 2020 Sep 7. doi:10.23750/abm.v91i3.9718


2. Nejadghaderi SA, Roshani S, Mohammadi E, Yoosefi M, Rezaei N, Esfahani Z, Azadnajafabad S, Ahmadi N, Shahin S, Kazemi A, Namazi Shabestari A, Khosravi A, Mokdad AH, Larijani B, Farzadfar F. The global, regional, and national burden and quality of care index (QCI) of colorectal cancer; a global burden of disease systematic analysis 1990-2019. PLoS One. 2022 Apr 21;17(4):e0263403. doi: 10.1371/journal.pone.0263403. PMID: 35446852; PMCID: PMC9022854.


3. Nejadghaderi SA, Nazemalhosseini-Mojarad E, Asadzadeh Aghdaei H. Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy. Med Hypotheses. 2021 Feb;147:110476. doi: 10.1016/j.mehy.2020.110476. Epub 2020 Dec 31. PMID: 33482620; PMCID: PMC7774521.


4. Nejadghaderi SA, Safiri S. The dilemma of herd immunity for COVID-19. J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26768. Epub ahead of print. PMID: 33386744.


5. Nejadghaderi SA, Saghazadeh A, Rezaei N. Health Care Policies and COVID-19 Prevalence: Is There Any Association? Int J Health Serv. 2021 Mar 9:20731421993940. doi: 10.1177/0020731421993940. Epub ahead of print. PMID: 33686893.


6. Nejadghaderi SA, Moghaddam SS, Azadnajafabad S, Rezaei N, Rezaei N, Tavangar SM, Jamshidi H, Mokdad AH, Naghavi M, Farzadfar F, Larijani B. Burden of thyroid cancer in North Africa and Middle East 1990-2019. Front Oncol. 2022 Sep 23;12:955358. doi: 10.3389/fonc.2022.955358. PMID: 36212501; PMCID: PMC9538696.


7. Nejadghaderi SA, Ahmadi N, Rashidi MM, Ghanbari A, Noori M, Abbasi-Kangevari M, Nasserinejad M, Rezaei N, Yoosefi M, Fattahi N, Ghasemi E, Farzi Y, Abdolhamidi E, Darman M, Djalalinia S, Farzadfar F. Physical activity pattern in Iran: Findings from STEPS 2021. Front Public Health. 2023 Jan 4;10:1036219. doi: 10.3389/fpubh.2022.1036219. PMID: 36684955; PMCID: PMC9846211.


8. Nejadghaderi SA, Balibegloo M, Saghazadeh A, Rezaei N. Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review. PLoS One. 2022 Jul 18;17(7):e0271506. doi: 10.1371/journal.pone.0271506. PMID: 35849585; PMCID: PMC9292075.


9. Nejadghaderi SA, Balibegloo M, Noori M, Fayyaz F, Saghazadeh A, Rezaei N. Clinical efficacy and safety of bispecific antibodies for the treatment of solid tumors: a systematic review and meta-analysis. Expert Rev Anticancer Ther. 2023 Mar;23(3):307-318. doi: 10.1080/14737140.2023.2183847. Epub 2023 Mar 1. PMID: 36856069.

10.  Nejadghaderi SA, Kolahi AA, Noori M, Sullman MJM, Safiri S. The burden of pancreatic cancer and its attributable risk factors in the Middle East and North Africa region, 1990-2019. J Gastroenterol Hepatol. 2023 May 23. doi: 10.1111/jgh.16217. Epub ahead of print. PMID: 37218385

11.  Nejadghaderi, Seyed Aria, et al. "Immune Checkpoint Inhibition for Pancreatic Cancer." ACTA MEDICA IRANICA (2023).

12.  Nejadghaderi SA, Saeedi Moghaddam S, Keykhaei M, Shobeiri P, Rezaei N, Rezaei N, Naghavi M, Larijani B, Farzadfar F. Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019. Front Endocrinol (Lausanne). 2023 Feb 27;14:1115833. doi: 10.3389/fendo.2023.1115833. PMID: 36923218; PMCID: PMC10010168.

13.  Nejadghaderi SA, Grieger JA, Karamzad N, Kolahi AA, Sullman MJM, Safiri S, Sabour S. Burden of diseases attributable to excess body weight in the Middle East and North Africa region, 1990-2019. Sci Rep. 2023 Nov 20;13(1):20338. doi: 10.1038/s41598-023-46702-y. PMID: 37990049; PMCID: PMC10663478.

14.  Nejadghaderi SA, Mousavi SE, Sullman MJM, Kolahi AA, Namazi Shabestari A, Safiri S. The burden of neck pain among adults aged 70 years and older in Iran, 1990-2019. Health Sci Rep. 2023 Nov 8;6(11):e1477. doi: 10.1002/hsr2.1477. PMID: 38028676; PMCID: PMC10630745.

15. Nejadghaderi SA, Balibegloo M, Rezaei N. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons. Health Sci Rep. 2024 Jun 3;7(6):e2165. doi: 10.1002/hsr2.2165. PMID: 38835932; PMCID: PMC11147813.


16. Zangiabadian, M., Nejadghaderi, S. A., Mirsaeidi, M., Hajikhani, B., Goudarzi, M., Goudarzi, H., Mardani, M., & Nasiri, M. J. (2020). Protective effect of influenza vaccination on cardiovascular diseases: a systematic review and meta-analysis. Scientific reports, 10(1), 20656. https://doi.org/10.1038/s41598-020-77679-7


17. Hosseinpour, M., Maleki, F., Khoramdad, M., Sullman, M., Nejadghaderi, S. A., Kolahi, A. A., & Safiri, S. (2021). A systematic literature review of observational studies of the bilateral association between diabetes and migraines. Diabetes & Metabolic Syndrome: Clinical Research & Reviews.


18. Zangiabadian, M., Nejadghaderi, S. A., Zahmatkesh, M. M., Hajikhani, B., Mirsaeidi, M., & Nasiri, M. J. (2021). The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review. Frontiers in Endocrinology, 12, 263.


19. Movahed, S. M. M., Akhavizadegan, H., Dolatkhani, F., Nejadghaderi, S. A., Aghajani, F., Gangi, M. F., ... & Ghasemi, H. (2021). Different incidences of acute kidney injury (AKI) and outcomes in COVID‐19 patients with and without non‐azithromycin antibiotics: a retrospective study. Journal of medical virology.


20. Noori M, Nejadghaderi SA, Rezaei N. "Original Antigenic Sin": A potential threat beyond the development of booster vaccination against novel SARS-CoV-2 variants. Infect Control Hosp Epidemiol. 2021 May 3:1-6. doi: 10.1017/ice.2021.199. Epub ahead of print. PMID: 33938416.


21. Balibegloo M, Nejadghaderi SA, Sadeghalvad M, Soleymanitabar A, Nezamabadi SS, Saghazadeh A, Rezaei N. Adverse events associated with immune checkpoint inhibitors in patients with breast cancer: A systematic review and meta-analysis. International Immunopharmacology. 2021 Jul 1;96:107796.


22. Shokri P, Golmohammadi S, Noori M, Nejadghaderi SA, Carson‐Chahhoud K, Safiri S. The relationship between blood groups and risk of infection with SARS‐CoV‐2 or development of severe outcomes: A review.


23. Noori M, Nejadghaderi SA, Sullman MJM, Carson-Chahhoud K, Kolahi AA, Safiri S. Epidemiology, prognosis and management of potassium disorders in Covid-19. Rev Med Virol. 2021 Jun 2:e2262. doi: 10.1002/rmv.2262. Epub ahead of print. PMID: 34077995.


24. Shaafi S, Hadisi F, Mahmoudinezhad M, Razmi H, Nejadghaderi SA, Khalili M. The significance of the oxidative stress markers in the one-year prognosis of patients with acute ischemic stroke: a case-control study. BMC Neurol. 2021 Jul 2;21(1):258. doi: 10.1186/s12883-021-02257-x. PMID: 34215195; PMCID: PMC8252289.


25. Noori M, Nejadghaderi SA, Arshi S, Carson-Chahhoud K, Ansarin K, Kolahi AA, Safiri S. Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies. Rev Med Virol. 2021 Jul 19:e2277. doi: 10.1002/rmv.2277. Epub ahead of print. PMID: 34286893.


26. Noori M, Nejadghaderi SA, Sullman MJM, Carson-Chahhoud K, Ardalan M, Kolahi AA, Safiri S. How SARS-CoV-2 might affect potassium balance via impairing epithelial sodium channels? Mol Biol Rep. 2021 Aug 15:1–7. doi: 10.1007/s11033-021-06642-0. Epub ahead of print. PMID: 34392451; PMCID: PMC8364628.


27. Safiri S, Kolahi AA, Noori M, Nejadghaderi SA, Karamzad N, Bragazzi NL, Sullman MJM, Abdollahi M, Collins GS, Kaufman JS, Grieger JA. Burden of anemia and its underlying causes in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. J Hematol Oncol. 2021 Nov 4;14(1):185. doi: 10.1186/s13045-021-01202-2. PMID: 34736513; PMCID: PMC8567696.


28. Bragazzi NL, Kolahi AA, Nejadghaderi SA, Lochner P, Brigo F, Naldi A, Lanteri P, Garbarino S, Sullman MJM, Dai H, Wu J, Kong JD, Jahrami H, Sohrabi MR, Safiri S. Global, regional, and national burden of Guillain-Barré syndrome and its underlying causes from 1990 to 2019. J Neuroinflammation. 2021 Nov 11;18(1):264. doi: 10.1186/s12974-021-02319-4. PMID: 34763713; PMCID: PMC8581128.


29. Noori M, Nejadghaderi SA, Sullman MJM, Carson-Chahhoud K, Ardalan M, Kolahi AA, Safiri S. A Review on the Possible Pathophysiology of Potassium Abnormalities in COVID-19. Iran J Kidney Dis. 2021 Dec;15(6):397-407. PMID: 34930851.


30. Fazlollahi A, Zahmatyar M, Noori M, Nejadghaderi SA, Sullman MJM, Shekarriz-Foumani R, Kolahi AA, Singh K, Safiri S. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol. 2021 Dec 17:e2318. doi: 10.1002/rmv.2318. Epub ahead of print. PMID: 34921468.


31. Kazeminasab S, Nejadghaderi SA, Amiri P, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S. Neck pain: global epidemiology, trends and risk factors. BMC Musculoskelet Disord. 2022 Jan 3;23(1):26. doi: 10.1186/s12891-021-04957-4. PMID: 34980079; PMCID: PMC8725362.


32. Ahmadzad-Asl M, Davoudi F, Mohamadi S, Hadi F, Nejadghaderi SA, Mirbehbahani SH, Jabbarinejad R, Saneh S, Arshadi M, Naserbakht M, Sinyor M, Kabir A, Shamshiri A. Systematic review and meta-analysis of the placebo effect in panic disorder: Implications for research and clinical practice. Aust N Z J Psychiatry. 2022 Jan 7:48674211068793. doi: 10.1177/00048674211068793. Epub ahead of print. PMID: 34996304.


33. Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-Chahhoud K, Kolahi AA, Safiri S. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Front Immunol. 2022 Jan 20;12:785946. doi: 10.3389/fimmu.2021.785946. PMID: 35126355; PMCID: PMC8815083.


34. Safiri S, Carson-Chahhoud K, Karamzad N, Sullman MJM, Nejadghaderi SA, Taghizadieh A, Bell AW, Kolahi AA, Ansarin K, Mansournia MA, Collins GS, Kaufman JS. Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019. Chest. 2022 Feb;161(2):318-329. doi: 10.1016/j.chest.2021.09.042. Epub 2021 Oct 23. PMID: 34699773.


35. Safiri S, Karamzad N, Kaufman JS, Nejadghaderi SA, Bragazzi NL, Sullman MJM, Almasi-Hashiani A, Mansournia MA, Collins GS, Kolahi AA, Jemal A. Global, regional, and national burden of cancers attributable to excess body weight in 204 countries and territories, 1990 to 2019. Obesity (Silver Spring). 2022 Feb;30(2):535-545. doi: 10.1002/oby.23355. Epub 2022 Jan 18. PMID: 35041300.


36. Jaberinezhad M, Farhoudi M, Nejadghaderi SA, Alizadeh M, Sullman MJM, Carson-Chahhoud K, Collins GS, Safiri S. The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022 Feb 17;12(1):2700. doi: 10.1038/s41598-022-06418-x. PMID: 35177688; PMCID: PMC8854638.


37. Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M, Sullman MJM, Kolahi AA, Safiri S. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Front Neurol. 2022 Feb 23;12:800605. doi: 10.3389/fneur.2021.800605. PMID: 35281991; PMCID: PMC8904749.


38. Safiri S, Karamzad N, Kaufman JS, Bell AW, Nejadghaderi SA, Sullman MJM, Moradi-Lakeh M, Collins G, Kolahi AA. Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019: Results From the Global Burden of Disease Study 2019. Front Endocrinol (Lausanne). 2022 Feb 25;13:838027. doi: 10.3389/fendo.2022.838027. PMID: 35282442; PMCID: PMC8915203.


39. Safiri S, Karamzad N, Singh K, Carson-Chahhoud K, Adams C, Nejadghaderi SA, Almasi-Hashiani A, Sullman MJM, Mansournia MA, Bragazzi NL, Kaufman JS, Collins GS, Kolahi AA. Burden of ischemic heart disease and its attributable risk factors in 204 countries and territories, 1990-2019. Eur J Prev Cardiol. 2022 Mar 11;29(2):420-431. doi: 10.1093/eurjpc/zwab213. PMID: 34922374.


40. Motlagh Asghari K, Nejadghaderi SA, Alizadeh M, Sanaie S, Sullman MJM, Kolahi AA, Avery J, Safiri S. Burden of polycystic ovary syndrome in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022 Apr 29;12(1):7039. doi: 10.1038/s41598-022-11006-0. PMID: 35488014; PMCID: PMC9052181.


41. Noori M, Shokri P, Nejadghaderi SA, Golmohammadi S, Carson-Chahhoud K, Bragazzi NL, Ansarin K, Kolahi AA, Arshi S, Safiri S. ABO blood groups and risk of human immunodeficiency virus infection: A systematic review and meta-analysis. Rev Med Virol. 2022 May;32(3):e2298. doi: 10.1002/rmv.2298. Epub 2021 Sep 30. PMID: 34590759.


42. Safiri S, Nejadghaderi SA, Karamzad N, Carson-Chahhoud K, Bragazzi NL, Sullman MJM, Almasi-Hashiani A, Mansournia MA, Collins GS, Kaufman JS, Kolahi AA. Global, regional, and national cancer deaths and disability-adjusted life-years (DALYs) attributable to alcohol consumption in 204 countries and territories, 1990-2019. Cancer. 2022 May 1;128(9):1840-1852. doi: 10.1002/cncr.34111. Epub 2022 Mar 3. PMID: 35239973.


43. Sadeghalvad M, Mansourabadi AH, Noori M, Nejadghaderi SA, Masoomikarimi M, Alimohammadi M, Rezaei N. Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies. Rev Med Virol. 2022 May 1:e2359. doi: 10.1002/rmv.2359. Epub ahead of print. PMID: 35491495.


44. Safiri S, Noori M, Nejadghaderi SA, Karamzad N, Carson-Chahhoud K, Sullman MJM, Collins GS, Kolahi AA, Avery J. Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990-2019. Hum Reprod. 2022 May 19:deac091. doi: 10.1093/humrep/deac091. Epub ahead of print. PMID: 35586937.


45. Shaafi S, Bonakdari E, Sadeghpour Y, Nejadghaderi SA. Correlation between red blood cell distribution width, neutrophil to lymphocyte ratio, and neutrophil to platelet ratio with 3-month prognosis of patients with intracerebral hemorrhage: a retrospective study. BMC Neurol. 2022 May 24;22(1):191. doi: 10.1186/s12883-022-02721-2. PMID: 35610607; PMCID: PMC9128218.


46. Safiri S, Nejadghaderi SA, Abdollahi M, Carson-Chahhoud K, Kaufman JS, Bragazzi NL, Moradi-Lakeh M, Mansournia MA, Sullman MJM, Almasi-Hashiani A, Taghizadieh A, Collins GS, Kolahi AA. Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990-2019. Cancer Med. 2022 May 27. doi: 10.1002/cam4.4647. Epub ahead of print. PMID: 35621231.


47. Shamekh A, Alizadeh M, Nejadghaderi SA, Sullman MJM, Kaufman JS, Collins GS, Kolahi A-A and Safiri S (2022) The Burden of Osteoarthritis in the Middle East and North Africa Region From 1990 to 2019. Front. Med. 9:881391. doi: 10.3389/fmed.2022.881391


48. Noori M, Azizi S, Abbasi Varaki F, Nejadghaderi SA, Bashash D. A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies. Int Immunopharmacol. 2022 Sep;110:109046. doi: 10.1016/j.intimp.2022.109046. Epub 2022 Jul 12. PMID: 35843148; PMCID: PMC9273573.


49. Rezaei Tolzali MM, Noori M, Shokri P, Rahmani S, Khanzadeh S, Nejadghaderi SA, Fazlollahi A, Sullman MJM, Singh K, Kolahi AA, Arshi S, Safiri S. Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review. Rev Med Virol. 2022 Aug 27:e2388. doi: 10.1002/rmv.2388. Epub ahead of print. PMID: 36029180; PMCID: PMC9539231.


50. Zangiabadian M, Golmohammadi S, Nejadghaderi SA, Zahmatkesh MM, Nasiri MJ, Sadeghian M. The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis. Front Psychiatry. 2022 Sep 26;13:1003257. doi: 10.3389/fpsyt.2022.1003257. PMID: 36226100; PMCID: PMC9548642.


51. Fazlollahi A, Zahmatyar M, Alizadeh H, Noori M, Jafari N, Nejadghaderi SA, Sullman MJM, Gharagozli K, Kolahi AA, Safiri S. Association between gout and the development of Parkinson's disease: a systematic review and meta-analysis. BMC Neurol. 2022 Oct 11;22(1):383. doi: 10.1186/s12883-022-02874-0. PMID: 36221048; PMCID: PMC9552480.


52. Araj-Khodaei M, Sanaie S, Nejadghaderi SA, Sullman MJM, Samei-Sis S, Taheri-Targhi S, Yousefi Z, Matlabi H, Safiri S, Azizi-Zeinalhajlou A. Profile of Tabriz Older People Health Survey (TOPS-2019): a representative community-based cross-sectional study. Sci Rep. 2022 Oct 25;12(1):17879. doi: 10.1038/s41598-022-22710-2. PMID: 36284173; PMCID: PMC9596475.


53. Safiri S, Noori M, Nejadghaderi SA, Shamekh A, Karamzad N, Sullman MJM, Grieger JA, Collins GS, Abdollahi M, Kolahi AA. The estimated burden of bulimia nervosa in the Middle East and North Africa region, 1990-2019. Int J Eat Disord. 2022 Oct 27. doi: 10.1002/eat.23835. Epub ahead of print. PMID: 36301044.


54. Safiri S, Kolahi AA, Noori M, Nejadghaderi SA, Aslani A, Sullman MJM, Farhoudi M, Araj-Khodaei M, Collins GS, Kaufman JS, Gharagozli K. Correction: Burden of tension-type headache in the Middle East and North Africa region, 1990-2019. J Headache Pain. 2022 Aug 2;23(1):94. doi: 10.1186/s10194-022-01454-4. Erratum for: J Headache Pain. 2022 Jul 6;23(1):77. PMID: 35915407; PMCID: PMC9344607.


55. Safiri S, Nejadghaderi SA, Karamzad N, Kaufman JS, Carson-Chahhoud K, Bragazzi NL, Sullman MJM, Beyranvand MR, Mansournia MA, Almasi-Hashiani A, Collins GS, Kolahi AA. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019. Front Endocrinol (Lausanne). 2022 Jul 19;13:879890. doi: 10.3389/fendo.2022.879890. PMID: 35966097; PMCID: PMC9366927.


56. Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Ahmadian Heris J, Ansarin K, Mansournia MA, Collins GS, Kolahi AA, Kaufman JS. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019. BMJ. 2022 Jul 27;378:e069679. doi: 10.1136/bmj-2021-069679. PMID: 35896191; PMCID: PMC9326843.


57. Mohamadi S, Ahmadzad-Asl M, Nejadghaderi SA, Jabbarinejad R, Mirbehbahani SH, Sinyor M, Richter MA, Davoudi F. Systematic Review and Meta-Analysis of the Placebo Effect and its Correlates in Obsessive Compulsive Disorder. Can J Psychiatry. 2022 Jul 25:7067437221115029. doi: 10.1177/07067437221115029. Epub ahead of print. PMID: 35876317.


58. Safiri S, Noori M, Nejadghaderi SA, Sullman MJM, Bragazzi NL, Almasi-Hashiani A, Mansournia MA, Kolahi AA. Burden of female breast cancer in the Middle East and North Africa region, 1990-2019. Arch Public Health. 2022 Jul 11;80(1):168. doi: 10.1186/s13690-022-00918-y. PMID: 35818086; PMCID: PMC9272597.


59. Rezaee M, Esfahani Z, Nejadghaderi SA, Abbasi-Kangevari M, Saeedi Moghaddam S, Ghanbari A, Ghamari A, Golestani A, Foroutan Mehr E, Kazemi A, Haghshenas R, Moradi M, Kompani F, Rezaei N, Larijani B. Estimating the burden of diseases attributable to lead exposure in the North Africa and Middle East region, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019. Environ Health. 2022 Oct 29;21(1):105. doi: 10.1186/s12940-022-00914-3. PMID: 36309664; PMCID: PMC9617306.


60. Abolghasemi M, Ali Ashrafi S, Asadi M, Shanehbandi D, Sadigh Etehad S, Poursaei E, Nejadghaderi SA, Shaafi S. MicroRNAs expression in peripheral blood mononuclear cells of patients with multiple sclerosis propose. Mol Biol Rep. 2022 Nov 1. doi: 10.1007/s11033-022-07905-0. Epub ahead of print. PMID: 36319782.


61. Ali Ashrafi S, Asadi M, Shanehbandi D, Sadigh Eteghad S, Fazlollahi A, Nejadghaderi SA, Shaafi S. Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study. BMC Neurol. 2022 Nov 3;22(1):405. doi: 10.1186/s12883-022-02909-6. PMID: 36329419; PMCID: PMC9632146.


62. Mousavi SE, Nejadghaderi SA, Khabbazi A, Alizadeh M, Sullman MJM, Kaufman JS, Collins GS, Safiri S. The burden of rheumatoid arthritis in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022 Nov 11;12(1):19297. doi: 10.1038/s41598-022-22310-0. PMID: 36369238; PMCID: PMC9652423.


63. Safiri S, Nejadghaderi SA, Noori M, Sullman MJM, Collins GS, Kaufman JS, Kolahi AA. Burden of diseases and injuries attributable to alcohol consumption in the Middle East and North Africa region, 1990-2019. Sci Rep. 2022 Nov 11;12(1):19301. doi: 10.1038/s41598-022-22901-x. PMID: 36369336; PMCID: PMC9652338.


64. Feizi H, Alizadeh M, Nejadghaderi SA, Noori M, Sullman MJM, Ahmadian Heris J, Kolahi AA, Collins GS, Safiri S. The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019. Respir Res. 2022 Nov 19;23(1):319. doi: 10.1186/s12931-022-02242-z. PMID: 36403049; PMCID: PMC9675283.


65. Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Karamzad N, Sullman MJM, Pirotta S, Collins GS, Abdollahi M, Kolahi AA. Comparison of the burden of anorexia nervosa in the Middle East and North Africa region between 1990 and 2019. J Eat Disord. 2022 Dec 10;10(1):192. doi: 10.1186/s40337-022-00718-3. PMID: 36496474; PMCID: PMC9738022.


66. Ghasemi H, Kazemian S, Nejadghaderi SA, Shafie M. Takotsubo syndrome and COVID-19: A systematic review. Health Sci Rep. 2022 Dec 2;6(1):e972. doi: 10.1002/hsr2.972. PMID: 36479387; PMCID: PMC9718950.


67. Amiri F, Kolahi AA, Nejadghaderi SA, Noori M, Khabbazi A, Sullman MJM, Kaufman JS, Collins GS, Safiri S. The Burden of Gout and Its Attributable Risk Factors in the Middle East and North Africa Region, 1990 to 2019. J Rheumatol. 2022 Sep 1:jrheum.220425. doi: 10.3899/jrheum.220425. Epub ahead of print. PMID: 36455948.


68. Ashrafi-Asgarabad A, Bokaie S, Razmyar J, Akbarein H, Nejadghaderi SA, Carson-Chahhoud K, Sullman MJM, Kaufman JS, Safiri S. The burden of lower respiratory infections and their underlying etiologies in the Middle East and North Africa region, 1990-2019: results from the Global Burden of Disease Study 2019. BMC Pulm Med. 2023 Jan 4;23(1):2. doi: 10.1186/s12890-022-02301-7. PMID: 36600241; PMCID: PMC9811697.


69. Safiri S, Mahmoodpoor A, Kolahi AA, Nejadghaderi SA, Sullman MJM, Mansournia MA, Ansarin K, Collins GS, Kaufman JS, Abdollahi M. Global burden of lower respiratory infections during the last three decades. Front Public Health. 2023 Jan 9;10:1028525. doi: 10.3389/fpubh.2022.1028525. PMID: 36699876; PMCID: PMC9869262.


70. Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Sullman MJM, Araj-Khodaei M, Singh K, Kolahi AA, Gharagozli K. The burden of Parkinson's disease in the Middle East and North Africa region, 1990-2019: results from the global burden of disease study 2019. BMC Public Health. 2023 Jan 16;23(1):107. doi: 10.1186/s12889-023-15018-x. PMID: 36642724; PMCID: PMC9841703.


71. Safiri S, Nejadghaderi SA, Noori M, Sullman MJM, Collins GS, Kaufman JS, Hill CL, Kolahi AA. The burden of low back pain and its association with socio-demographic variables in the Middle East and North Africa region, 1990-2019. BMC Musculoskelet Disord. 2023 Jan 23;24(1):59. doi: 10.1186/s12891-023-06178-3. PMID: 36683025; PMCID: PMC9869505.


72. Safiri S, Noori M, Nejadghaderi SA, Mousavi SE, Sullman MJM, Araj-Khodaei M, Collins GS, Kolahi AA, Gharagozli K. The burden of Alzheimer's disease and other types of dementia in the Middle East and North Africa region, 1990-2019. Age Ageing. 2023 Mar 1;52(3):afad042. doi: 10.1093/ageing/afad042. PMID: 36995136.


73. Tondro Anamag F, Noori M, Nejadghaderi SA, Sullman MJM, Grieger JA, Kolahi AA, Safiri S. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019. Cancer Med. 2023 Apr;12(8):10031-10044. doi: 10.1002/cam4.5743. Epub 2023 Mar 23. PMID: 36951550; PMCID: PMC10166946.


74. Fazlollahi A, Zahmatyar M, ZareDini M, Golabi B, Nejadghaderi SA, Sullman MJM, Gharagozli K, Kolahi AA, Safiri S. Adverse Events of Cannabidiol Use in Patients With Epilepsy: A Systematic Review and Meta-analysis. JAMA Netw Open. 2023 Apr 3;6(4):e239126. doi: 10.1001/jamanetworkopen.2023.9126. PMID: 37079302; PMCID: PMC10119734.

75.  Ammar A, Trabelsi K, Hermassi S, Kolahi AA, Mansournia MA, Jahrami H, Boukhris O, Boujelbane MA, Glenn JM, Clark CCT, Nejadghaderi A, Puce L, Safiri S, Chtourou H, Schöllhorn WI, Zmijewski P, Bragazzi NL. Global disease burden attributed to low physical activity in 204 countries and territories from 1990 to 2019: Insights from the Global Burden of Disease 2019 Study. Biol Sport. 2023 Jul;40(3):835-855. doi: 10.5114/biolsport.2023.121322. Epub 2022 Nov 22. PMID: 37398951; PMCID: PMC10286621.

76.  Safiri S, Mousavi SE, Nejadghaderi SA, Noori M, Sullman MJM, Amiri S, Kolahi AA. The Burden of Attention-Deficit Hyperactivity Disorder (ADHD) in the Middle East and North Africa Region, 1990 to 2019. J Atten Disord. 2023 Jul 25:10870547231187161. doi: 10.1177/10870547231187161. Epub ahead of print. PMID: 37491897.

77.  Zahmatyar M, Fazlollahi A, Motamedi A, Zolfi M, Seyedi F, Nejadghaderi SA, Sullman MJM, Mohammadinasab R, Kolahi AA, Arshi S, Safiri S. Human monkeypox: history, presentations, transmission, epidemiology, diagnosis, treatment, and prevention. Front Med (Lausanne). 2023 Jul 20;10:1157670. doi: 10.3389/fmed.2023.1157670. PMID: 37547598; PMCID: PMC10397518.

78.  Sedaghat Z, Khodakarim S, Nejadghaderi SA, Sabour S. Association between metabolic syndrome and myocardial infarction among patients with excess body weight: a systematic review and meta-analysis. BMC Public Health. 2024 Feb 12;24(1):444. doi: 10.1186/s12889-024-17707-7. PMID: 38347488; PMCID: PMC10863149.

79.  Safiri S, Jaberinezhad M, Mousavi SE, Motlagh Asghari K, Shamekh A, Nejadghaderi SA, Sullman MJM, Houshyar Y, Behrangi E, Kolahi AA. The burden of dermatitis from 1990-2019 in the Middle East and North Africa region. BMC Public Health. 2024 Feb 7;24(1):399. doi: 10.1186/s12889-024-17836-z. PMID: 38326798; PMCID: PMC10848450.

80.  Safiri S, Hassanzadeh K, Janbaz Alamdary S, Mousavi SE, Nejadghaderi SA, Sullman MJM, Naghdi-Sedeh N, Kolahi AA. The burden of testicular cancer from 1990 to 2019 in the Middle East and North Africa region. Front Oncol. 2023 Dec 22;13:1276965. doi: 10.3389/fonc.2023.1276965. PMID: 38188291; PMCID: PMC10767553.

81.  Daei Sorkhabi A, ZareDini M, Fazlollahi A, Sarkesh A, Naseri A, Mousavi SE, Nejadghaderi SA, Sullman MJM, Kolahi AA, Safiri S. The safety and efficacy of tislelizumab, alone or in combination with chemotherapy, for the treatment of non-small cell lung cancer: a systematic review of clinical trials. BMC Pulm Med. 2023 Dec 8;23(1):495. doi: 10.1186/s12890-023-02755-3. PMID: 38066549; PMCID: PMC10704633.

82.  Safiri S, Mousavi SE, Noori M, Nejadghaderi SA, Sullman MJM, Singh K, Kolahi AA. The burden of rheumatic heart disease in the Middle East and North Africa region, 1990-2019. Arch Cardiovasc Dis. 2023 Dec;116(12):542-554. doi: 10.1016/j.acvd.2023.09.005. Epub 2023 Oct 6. PMID: 37863752.

83.  Mousavi SE, Ilaghi M, Aslani A, Yekta Z, Nejadghaderi SA. A population-based study on incidence trends of myeloma in the United States over 2000-2020. Sci Rep. 2023 Nov 24;13(1):20705. doi: 10.1038/s41598-023-47906-y. PMID: 38001246; PMCID: PMC10673923.

84.  Ahangar-Sirous R, Alizadeh M, Nejadghaderi SA, Noori M, Khabbazi A, Sullman MJM, Kolahi AA, Collins GS, Safiri S. The burden of neck pain in the Middle East and North Africa region, 1990-2019. Heliyon. 2023 Oct 21;9(11):e21296. doi: 10.1016/j.heliyon.2023.e21296. PMID: 38027849; PMCID: PMC10643100.

85.  Marghoub S, Sanaie S, Sullman MJM, Nejadghaderi SA, Safiri S, Mohammadinasab R. Obesity from a sign of being rich to a disease of the new age: A historical review. Health Sci Rep. 2023 Nov 1;6(11):e1670. doi: 10.1002/hsr2.1670. PMID: 37920661; PMCID: PMC10618901.

86.  Fazlollahi A, Zahmatyar M, Shamekh A, Motamedi A, Seyedi F, Seyedmirzaei H, Mousavi SE, Nejadghaderi SA, Sullman MJM, Kolahi AA, Arshi S, Safiri S. Electroencephalographic findings post-COVID-19 vaccination: A systematic review of case reports and case series. Rev Med Virol. 2023 Nov;33(6):e2484. doi: 10.1002/rmv.2484. Epub 2023 Oct 9. PMID: 37807809.

87.  Bastan MM, Nejadghaderi SA, Khanmohammadi S, Behnoush AH, Khalaji A, Malekpour MR, Rashidi MM, Azadnajafabad S, Azangou-Khyavy M, Momtazmanesh S, Payab M, Amini M. Burden of cardiometabolic disease attributable to sugar sweetened beverages consumption in North Africa and the Middle East from 1990 to 2021. J Diabetes Metab Disord. 2025 Feb 12;24(1):66. doi: 10.1007/s40200-025-01578-9. PMID: 39959579; PMCID: PMC11822180.

88.  Ghasemi H, Bastan MM, Najafi M, Nejadghaderi SA. Three decades of atrial fibrillation and flutter epidemiology and risk factors in Iran with a focus on the impact of COVID-19. Sci Rep. 2025 Mar 20;15(1):9697. doi: 10.1038/s41598-025-91737-y. PMID: 40113914; PMCID: PMC11926214.

89.  D'Costa MP, Alva MS, Nejadghaderi SA, Al Bloushi SH, Al Shizawi WIS, Muduli N, Ahuja S, Al-Amri S, Mosavi Jarrahi A, Al-Yateem N, Rahman SA, Al-Marzouqi AM. The Evaluation of Patient-Controlled Analgesia Compared to Standard Opioid Analgesic Therapy in Pain Management Among Patients With Sickle Cell Disease: A Systematic Review and Meta-Analysis Protocol. Health Sci Rep. 2025 Mar 18;8(3):e70577. doi: 10.1002/hsr2.70577. PMID: 40109702; PMCID: PMC11919697.

90.  Ahmed FR, Al-Yateem N, Nejadghaderi SA, Saifan AR, Farghaly Abdelaliem SM, AbuRuz ME. Harnessing machine learning for predicting successful weaning from mechanical ventilation: A systematic review. Aust Crit Care. 2025 Mar 8;38(3):101203. doi: 10.1016/j.aucc.2025.101203. Epub ahead of print. PMID: 40058181.

91.  Farrokhpour M, Forogh B, Gholampour G, Nejadghaderi SA, Habibzadeh A, Nakhostin-Ansari A, Seyedmirzaei H. Burden of Diseases Attributable to Low Physical Activity in the Middle East and North Africa: an Analysis Based on Global Burden of Disease Study. Balkan Med J. 2025 Mar 3;42(2):121-129. doi: 10.4274/balkanmedj.galenos.2025.2025-1-20. PMID: 40033634; PMCID: PMC11881527.

92.  Ebrahimi R, Masouri MM, Salehi Amniyeh Khozani AA, Mohammad Soltani S, Nejadghaderi SA. Effects of Vitamin D Supplementation on Blood Pressure in Patients With Type 1 Diabetes Mellitus: A Systematic Review of Clinical Trials. Health Sci Rep. 2025 Mar 2;8(3):e70524. doi: 10.1002/hsr2.70524. PMID: 40041785; PMCID: PMC11872689.

93.  Mousavi SE, Ilaghi M, Elahi Vahed I, Nejadghaderi SA. Epidemiology and socioeconomic correlates of gastric cancer in Asia: results from the GLOBOCAN 2020 data and projections from 2020 to 2040. Sci Rep. 2025 Feb 23;15(1):6529. doi: 10.1038/s41598-025-90064-6. PMID: 39988724; PMCID: PMC11847935.

94.  Mousavi SE, Ghasemi H, Najafi M, Nejadghaderi SA. Global Epidemiology and Socioeconomic Correlates of Salivary Gland Cancer From 2020 to 2040. Community Dent Oral Epidemiol. 2025 Feb 20. doi: 10.1111/cdoe.13033. Epub ahead of print. PMID: 39979564.

95.  Safiri S, Grieger JA, Ghaffari Jolfayi A, Mousavi SE, Nejadghaderi SA, Fazlollahi A, Sullman MJM, Karamzad N, Sahin F, Singh K, Collins GS, Kolahi AA. Burden of diseases attributable to excess body weight in 204 countries and territories, 1990-2019. Nutr J. 2025 Feb 4;24(1):23. doi: 10.1186/s12937-025-01082-z. PMID: 39905517; PMCID: PMC11796013.

96.  Abdolahinia Z, Nejadghaderi SA, Mehmandoost S, Haghdoost A, Iranpour A, Karamouzian M, Sharifi H. Self-perception of risk for HIV acquisition among people in prisons in Iran: A nationwide survey in 2017. BMC Public Health. 2025 Feb 1;25(1):415. doi: 10.1186/s12889-025-21518-9. PMID: 39893389; PMCID: PMC11787749.

97.  Ahmed FR, Al-Yateem N, Nejadghaderi SA, Gamil R, AbuRuz ME. Effect of acute kidney injury care bundle on kidney outcomes in cardiac patients receiving critical care: a systematic review and meta-analysis. BMC Nephrol. 2025 Jan 10;26(1):17. doi: 10.1186/s12882-025-03955-1. PMID: 39794703; PMCID: PMC11721091.

98.  Asghari KM, Zahmatyar M, Seyedi F, Motamedi A, Zolfi M, Alamdary SJ, Fazlollahi A, Shamekh A, Mousavi SE, Nejadghaderi SA, Mohammadinasab R, Ghazi-Sha'rbaf J, Karamzad N, Sullman MJM, Kolahi AA, Safiri S. Gout: global epidemiology, risk factors, comorbidities and complications: a narrative review. BMC Musculoskelet Disord. 2024 Dec 19;25(1):1047. doi: 10.1186/s12891-024-08180-9. PMID: 39702222; PMCID: PMC11660718.

99.  Ebrahimi R, Farsi Y, Nejadghaderi SA. Fecal microbiota transplantation for glaucoma; a potential emerging treatment strategy. Curr Res Microb Sci. 2024 Nov 13;7:100314. doi: 10.1016/j.crmicr.2024.100314. PMID: 39726974; PMCID: PMC11670420.

100.                   Safiri S, Ghaffari Jolfayi A, Mousavi SE, Nejadghaderi SA, Sullman MJM, Kolahi AA. Global burden of multiple sclerosis and its attributable risk factors, 1990-2019. Front Neurol. 2024 Oct 25;15:1448377. doi: 10.3389/fneur.2024.1448377. PMID: 39524915; PMCID: PMC11545682.

101.                   Ebrahimi R, Masouri MM, Salehi Amniyeh Khozani AA, Ramadhan Hussein D, Nejadghaderi SA. Safety and efficacy of fecal microbiota transplantation for viral diseases: A systematic review of clinical trials. PLoS One. 2024 Oct 21;19(10):e0311731. doi: 10.1371/journal.pone.0311731. PMID: 39432486; PMCID: PMC11493255.

102.                   Nejadghaderi SA, Mousavi SE, Fazlollahi A, Motlagh Asghari K, Garfin DR. Efficacy of yoga for posttraumatic stress disorder: A systematic review and meta-analysis of randomized controlled trials. Psychiatry Res. 2024 Oct;340:116098. doi: 10.1016/j.psychres.2024.116098. Epub 2024 Jul 22. PMID: 39191128.

103.                   Aslani A, Soheili A, Mousavi SE, Ebrahimi A, Antar RM, Yekta Z, Nejadghaderi SA. Incidence trends of gastric cancer in the United States over 2000-2020: A population-based analysis. PLoS One. 2024 Sep 25;19(9):e0310040. doi: 10.1371/journal.pone.0310040. PMID: 39321169; PMCID: PMC11423999.

104.                   Mousavi SE, Seyedmirzaei H, Shahrokhi Nejad S, Nejadghaderi SA. Epidemiology and socioeconomic correlates of brain and central nervous system cancers in Asia in 2020 and their projection to 2040. Sci Rep. 2024 Sep 20;14(1):21936. doi: 10.1038/s41598-024-73277-z. PMID: 39304723; PMCID: PMC11415511.

105.                   Aslani A, Morsali S, Mousavi SE, Choupani S, Yekta Z, Nejadghaderi SA. Adult Hodgkin lymphoma incidence trends in the United States from 2000 to 2020. Sci Rep. 2024 Sep 3;14(1):20500. doi: 10.1038/s41598-024-69975-3. PMID: 39227605; PMCID: PMC11372180.

106.                   Mousavi SE, Ilaghi M, Mirzazadeh Y, Mosavi Jarrahi A, Nejadghaderi SA. Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020. Front Oncol. 2024 Sep 2;14:1398063. doi: 10.3389/fonc.2024.1398063. Erratum in: Front Oncol. 2024 Dec 02;14:1520064. doi: 10.3389/fonc.2024.1520064. PMID: 39286014; PMCID: PMC11402725.

107.                   Mousavi SE, Ilaghi M, Mahdavizadeh V, Ebrahimi R, Aslani A, Yekta Z, Nejadghaderi SA. A population-based study on incidence trends of small intestine cancer in the United States from 2000 to 2020. PLoS One. 2024 Aug 19;19(8):e0307019. doi: 10.1371/journal.pone.0307019. PMID: 39159196; PMCID: PMC11332941.

108.                   Zahmatyar M, Kharaz L, Abiri Jahromi N, Jahanian A, Shokri P, Nejadghaderi SA. The safety and efficacy of binimetinib for lung cancer: a systematic review. BMC Pulm Med. 2024 Aug 1;24(1):379. doi: 10.1186/s12890-024-03178-4. PMID: 39090580; PMCID: PMC11295668.

109.                   Mousavi SE, Ilaghi M, Aslani A, Najafi M, Yekta Z, Nejadghaderi SA. Laryngeal cancer incidence trends in the United States over 2000-2020: a population-based analysis. Arch Public Health. 2024 Jul 10;82(1):106. doi: 10.1186/s13690-024-01333-1. PMID: 38987838; PMCID: PMC11234729.

110.                   Safiri S, Hassanzadeh K, Ghaffari Jolfayi A, Mousavi SE, Motlagh Asghari K, Nejadghaderi SA, Naghdi-Sedeh N, Noori M, Sullman MJM, Collins GS, Kolahi AA. Kidney cancer in the Middle East and North Africa region: a 30-year analysis (1990-2019). Sci Rep. 2024 Jun 14;14(1):13710. doi: 10.1038/s41598-024-64521-7. PMID: 38877130; PMCID: PMC11178886.

111.                   Safiri S, Mousavi SE, Motlagh Asghari K, Nejadghaderi SA, Aletaha R, Sullman MJM, Singh K, Kolahi AA, Beyranvand MR. Burden of diseases due to high systolic blood pressure in the Middle East and North Africa region from 1990 to 2019. Sci Rep. 2024 Jun 13;14(1):13617. doi: 10.1038/s41598-024-64563-x. PMID: 38871791; PMCID: PMC11176357.

112.                   Safiri S, Mousavi SE, Nejadghaderi SA, Motlagh Asghari K, Karamzad N, Sullman MJM, Kolahi AA, Abdollahi M. Vitamin A deficiency in the MENA region: a 30-year analysis (1990-2019). Front Nutr. 2024 Jun 6;11:1413617. doi: 10.3389/fnut.2024.1413617. PMID: 38903625; PMCID: PMC11187328.

113.                   Mousavi SE, Ghasemi H, Najafi M, Yekta Z, Nejadghaderi SA. Incidence Trends of Vulvar Cancer in the United States: A 20-Year Population-Based Study. Cancer Rep (Hoboken). 2024 Jun;7(6):e2120. doi: 10.1002/cnr2.2120. PMID: 39031816; PMCID: PMC11190582.

114.                   Zangiabadian M, Jolfayi AG, Nejadghaderi SA, Amirkhosravi L, Sanjari M. The association between heavy metal exposure and obesity: A systematic review and meta-analysis. J Diabetes Metab Disord. 2023 Oct 28;23(1):11-26. doi: 10.1007/s40200-023-01307-0. PMID: 38932800; PMCID: PMC11196503.

115.                   Safiri S, Mousavi SE, Nejadghaderi SA, Noori M, Sullman MJM, Kolahi AA, Shekarriz-Foumani R. The burden of major depressive disorder in the Middle East and North Africa region, 1990-2019. Acta Neuropsychiatr. 2024 Jun;36(3):139-152. doi: 10.1017/neu.2023.42. Epub 2023 Sep 11. PMID: 37690795.

116.                   Mousavi SE, Najafi M, Aslani A, Fazlollahi A, Yekta Z, Sadri M, Nejadghaderi SA. A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020. Sci Rep. 2024 May 17;14(1):11294. doi: 10.1038/s41598-024-61748-2. PMID: 38760399; PMCID: PMC11101446.

117.                   Safiri S, Noori M, Nejadghaderi SA, Shamekh A, Sullman MJM, Collins GS, Kolahi AA. The burden of schizophrenia in the Middle East and North Africa region, 1990-2019. Sci Rep. 2024 Apr 27;14(1):9720. doi: 10.1038/s41598-024-59905-8. PMID: 38678101; PMCID: PMC11055947.

118.                   Sedaghat Z, Khodakarim S, Sabour S, Valizadeh M, Barzin M, Nejadghaderi SA, Azizi F. The effect of obesity phenotype changes on cardiovascular outcomes in adults older than 40 years in the prospective cohort of the Tehran lipids and glucose study (TLGS): joint model of longitudinal and time-to-event data. BMC Public Health. 2024 Apr 23;24(1):1126. doi: 10.1186/s12889-024-18577-9. PMID: 38654182; PMCID: PMC11040833.

119.                   Mousavi SE, Noori M, Marandi H, Fazlollahi A, Nejadghaderi SA, Rahmani S, Noordoost M, Karamzad N, Sullman MJM, Kolahi AA, Safiri S. The efficacy and safety of Nigella sativa in the management of osteoarthritis: A systematic review. Health Sci Rep. 2024 Apr 21;7(4):e1989. doi: 10.1002/hsr2.1989. PMID: 38650731; PMCID: PMC11033494.

120.                   Shahrokhi Nejad S, Golzari Z, Zangiabadian M, Salehi Amniyeh Khozani AA, Ebrahimi R, Nejadghaderi SA, Aletaha A. The association between zinc and prostate cancer development: A systematic review and meta-analysis. PLoS One. 2024 Mar 20;19(3):e0299398. doi: 10.1371/journal.pone.0299398. PMID: 38507438; PMCID: PMC10954196.

121.                   Mousavi SE, Ilaghi M, Hamidi Rad R, Nejadghaderi SA. Epidemiology and socioeconomic correlates of colorectal cancer in Asia in 2020 and its projection to 2040. Sci Rep. 2025 Jul 22;15(1):26639. doi: 10.1038/s41598-025-12545-y. PMID: 40695969; PMCID: PMC12284187.

122.                   Mousavi SE, Najafi M, Aslani A, Ghasemi H, Yekta Z, Nejadghaderi SA. Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States. Sci Rep. 2025 Jul 2;15(1):22634. doi: 10.1038/s41598-025-07472-x. PMID: 40594649; PMCID: PMC12214804.

123.                   Davari A, Piroozkhah M, Iranpour A, Nejadghaderi SA. The burden of age-related macular degeneration and its socioeconomic associates in the Eastern Mediterranean Region from 1990 to 2021. Sci Rep. 2025 Jul 1;15(1):21950. doi: 10.1038/s41598-025-04196-w. PMID: 40594270; PMCID: PMC12217938.

124.                   Aslani A, Najafi M, Mousavi SE, Marandi H, Yekta Z, Nejadghaderi SA. Trends of Non-Hodgkin Lymphoma Incidence Among Adults in the United States From 2000 to 2020. Cancer Rep (Hoboken). 2025 Jul;8(7):e70269. doi: 10.1002/cnr2.70269. PMID: 40583739; PMCID: PMC12207246.

125.                   Halimi A, Jarrahi AM, Kian N, Nejadghaderi SA, Jorjani G, Keramatinia A, Al-Marzouqi A, Shams J, Adel N. Factors related to the occurrence of mass psychogenic illness in schools: a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2025 Jun 19. doi: 10.1007/s00127-025-02949-6. Epub ahead of print. PMID: 40537604.

126.                   Sarkoohi Z, Bastan MM, Khajuei Gharaei MA, Iranmanesh M, Adinepour A, Khajezade R, Bahri F, Akhlaghi F, Kadkhodamanesh A, Pourghadamyari H, Sharifi H, Eslami O, Nejadghaderi SA. Epidemiological trends and burden of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa region: a 32-year analysis of health impact. J Health Popul Nutr. 2025 Jun 18;44(1):207. doi: 10.1186/s41043-025-00973-5. PMID: 40533853; PMCID: PMC12175313.

127.                   Ebrahimi R, Shahrokhi Nejad S, Fekri M, Nejadghaderi SA. Advancing prostate cancer treatment: the role of fecal microbiota transplantation as an adjuvant therapy. Curr Res Microb Sci. 2025 Jun 11;9:100420. doi: 10.1016/j.crmicr.2025.100420. PMID: 40600174; PMCID: PMC12212177.

128.                   Sharifi M, Nejadghaderi SA, Bazrafshani MS, Amiri E, Tavakoli F, Mehmandoost S, Alaama AS, Sharifi M, Karamouzian M, Sharifi H. CD4 cell counts at HIV diagnosis in the Eastern Mediterranean Region. Lancet HIV. 2025 Jun;12(6):e400-e401. doi: 10.1016/S2352-3018(25)00101-8. Epub 2025 Apr 28. PMID: 40311652.

129.                   Fekri M, Dehesh P, Tahmasbi Arashlow F, Layegh H, Zaresharifi S, Nejadghaderi SA. Epidemiology and socioeconomic factors of nonmelanoma skin cancer in the Middle East and North Africa 1990 to 2021. Sci Rep. 2025 May 23;15(1):17904. doi: 10.1038/s41598-025-99434-6. PMID: 40410346; PMCID: PMC12102319.

130.                   Honarmand AA, Nejadghaderi SA, Haghdoost A. The Benefits versus Risks of E-Cigarettes, Vapes, and Pods: A Review Article. Iranian Journal of Epidemiology. 2025 Jun 9.

131.                   Honarmand AA, Nejadghaderi SA, Naghibzadeh-Tahami A, Haghdoost A. Barriers to Screening for Cancers Included in the National Program of Cancer Early Detection in Iran. Iranian Journal of Culture and Health Promotion. 2025 Mar 10;8(4):408-14.

132.                   Rahmani A, Shahbandi A, Ghashghaie S, Ghodsi Z, Khazaeipour Z, Abbaszadeh M, Dabbagh Ohadi MA, Nejadghaderi SA, Atlasi R, Maasoumi R, Khodadoust E, Vaccaro AR, Rahimi-Movaghar V. Factors affecting sexual health in individuals with spinal cord injury: A systematic scoping review. Chin J Traumatol. 2025 May;28(3):193-200. doi: 10.1016/j.cjtee.2024.05.002. Epub 2024 May 22. PMID: 38816330; PMCID: PMC12166888.

133.                   Rezaee M, Azizi N, Danaei B, Davari A, Nejadghaderi SA, Sarmastzadeh T, Rahmannia M, Khalili F, Shahidi-Bonjar AH, Centis R, D'Ambrosio L, Sotgiu G, Migliori GB, Nasiri MJ. TB and interstitial lung disease: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2024 Mar 1;28(3):130-135. doi: 10.5588/ijtld.23.0428. PMID: 38454180.

134.                   Nejadghaderi SA, Khoshgoftar Z, Fazlollahi A, Nasiri MJ. Medical education during the coronavirus disease 2019 pandemic: an umbrella review. Front Med (Lausanne). 2024 Jul 5;11:1358084. doi: 10.3389/fmed.2024.1358084. PMID: 39036099; PMCID: PMC11257851.

135.                   Nejadghaderi SA, Bastan MM, Abdi M, Iranpour A, Sharifi H. National and subnational epidemiology and correlates of high alcohol use attributable burden in Iran from 1990 to 2021. Sci Rep. 2025 Mar 12;15(1):8596. doi: 10.1038/s41598-025-93160-9. PMID: 40074865; PMCID: PMC11904175.

136.                   Nejadghaderi SA, Bastan MM, Abdi M, Iranpour A, Sharifi H. National and sub-national HIV/AIDS epidemiology, socioeconomic influences, and risk factors in Iran from 1990 to 2021, global burden of disease 2021 study. Sci Rep. 2025 Jul 2;15(1):22493. doi: 10.1038/s41598-025-06499-4. PMID: 40594450; PMCID: PMC12216094.

137.                   Nejadghaderi SA, Kadkhodamanesh A, Mehmandoost S, Sharifi M, Tavakoli F, Bazrafshani MS, Khezri M, Mirzaie H, Nasiri N, Bajelan S, Sattari M, Iranpour A, Sharifi H. The prevalence of homelessness and its associated factors among people who inject drugs in Iran: results from nationwide bio-behavioral surveillance surveys in 2020 and 2023. BMC Public Health. 2025 Jun 2;25(1):2036. doi: 10.1186/s12889-025-23204-2. PMID: 40457346; PMCID: PMC12128355.

1.     Nejadghaderi, S.A., Rezaei, N. (2023). Health Crisis and Cancer Prevention: Friend or Foe. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-80962-1_321-1

2.     Nejadghaderi, S.A., Hanaei, S. (2024). Antley-Bixler Syndrome: Types 1 and 2. In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1889-1

3.     Nejadghaderi, S.A., Hanaei, S. (2024). Williams-Campbell Syndrome. In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_985-1

4.     Nejadghaderi, S.A., Hanaei, S. (2024). Ichthyosis, Mental Retardation, Dwarfism, and Renal Impairment. In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1046-1

5.     Nejadghaderi, S.A., Hanaei, S. (2024). Renal Dysplasia-Limb Defects Syndrome (RL Syndrome). In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1061-1

6.     Nejadghaderi, S.A., Hanaei, S. (2024). Homozygous 11p15-p14 Deletion Syndrome. In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1012-1

7.     Nejadghaderi, S.A., Hanaei, S. (2024). Chitayat Syndrome (CHYTS). In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_970-1

8.     Nejadghaderi, S.A., Hanaei, S. (2024). Trisomy X. In: Rezaei, N. (eds) Genetic Syndromes. Springer, Cham. https://doi.org/10.1007/978-3-319-66816-1_1881-1

• Nejadghaderi SA, Bastan MM, Abdi M, Iranpour A, Sharifi H. Three decades of HIV/AIDS in Iran: epidemiological trends, socioeconomic impacts, and risk factors. ESCMID Global. 11–15 April, 2025. Vienna, Austria.


• Abdolahinia Z, Nejadghaderi SA, Mehmandoost S, Haghdoost A, Iranpour A, Karamouzian M, Sharifi H. A nationwide survey on self-perception of HIV acquisition risk among people in prisons in Iran. ESCMID Global. 11–15 April, 2025. Vienna, Austria.


• Nejadghaderi SA. Personal hygiene and infectious diseases. Presented as concept map at the 2^nd International Congress on prevention strategies for healthcare-associated infections, Mashhad, Iran, April 2018


• Nejadghaderi SA, Razi S, Keshavarz-fathi M, Rezaei N. Immune checkpoint inhibition for pancreatic cancer. 4^th Universal Scientific Education and Research Network (USERN) Congress, Budapest, Hungary, November 2019 (Accepted Poster, Not Presented)


• Ansarinejad N, Nejadghaderi SA, Balasi J. Transitional cell carcinoma (TCC) of bladder with metastasis to lung and bones. 3^rd national congress on clinical case reports, Karaj, Iran, December 2019. (Poster Presentation)

Hamid Sharifi, DVM, PhD

• Director of HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Kerman University of Medical Sciences, Kerman, Iran.


• Affiliate, Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA


• [email protected]; [email protected]

Siamak Sabour, MD, PhD

• Assistant Professor of Epidemiology, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran


• [email protected]; [email protected]